This lawsuit seeks to restrict nationwide access to mifepristone, a medication used in over two-thirds of US abortions, and has already gained traction in Texas.
Judge Kacsmaryk, a Trump appointee, ruled that the lawsuit could proceed as it was too early in litigation to dismiss it based on venue disputes.
Despite the US Supreme Court's previous ruling that the activists lacked standing, attorneys general from Idaho, Kansas, and Missouri are now pursuing the case.
Julia Kaye of the ACLU criticized the continuation of this case, stating that it should have been concluded, given its previous legal setbacks.
Collection
[
|
...
]